Morphology and numerical characteristics of epidemic curves for SARS-Cov-II using Moyal distribution
Jose de Jesus Bernal-Alvarado, David Delepine (Guanajuato, University)

TL;DR
This study demonstrates that the Moyal distribution effectively models COVID-19 epidemic curves across various countries, providing insights into outbreak dynamics and the impact of public health measures.
Contribution
It introduces the use of the Moyal distribution to accurately fit and analyze SARS-CoV-2 epidemic curves and correlates parameters with public health policies.
Findings
Moyal distribution fits daily new cases data well across multiple countries.
Parameters of the distribution relate to the timing and intensity of outbreaks.
The approach can help evaluate the effectiveness of social distancing measures.
Abstract
In this paper, it is shown that the Moyal distribution is an excelent tool to study the SARS-Cov-II (Covid-19) epidemiological associated curves and its propagation. The Moyal parameters give all the information to describe the form and the impact of the illness outbreak in the different affected countries and its global impact. We checked that the Moyal distribution can accurately fit the daily report of {\it{new confirmed cases of infected people}} (NCC) per country, in that places where the contagion is reaching their final phase, describing the beginning, the most intense phase and the descend of the contagion, simultaneously . In order to achieve the purpose of this work, it is important to work with a complete and well compilated set of the data to be used to fit the curves. Data from European countries like France, Spain, Italy Belgium, Sweden, United Kingdom, Denmark and others…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · Data-Driven Disease Surveillance · COVID-19 Pandemic Impacts
